CLDI · Calidi Biotherapeutics Inc. Common Stock
View on chartInsiders & Stakes
| First Light Acquisition Group, LLC 10% Owner | ▼ Sell | Other | 1,931,852 Shares held | 9/12/2023 | View profile |
| Polar Asset Management Partners Inc. 10% Owner | ▼ Sell | Open Market | 412,800 Shares held | 10/19/2022 | View profile |
| Thomas A. Vecchiolla Director | ▲ Buy | Grant | 365,105 Shares held | 12/21/2023 | View profile |
| Alfonso G. Zulueta Director | ▲ Buy | Grant | 133,301 Shares held | 12/21/2023 | View profile |
| Scott Leftwich Director | ▲ Buy | Open Market | 130,650 Shares held | 8/21/2025 | View profile |
| Allan Camaisa CEO and Chairman of the Board | ▼ Sell | Open Market | 76,952 Shares held | 12/12/2025 | View profile |
| James A. Schoeneck Director | ▲ Buy | Open Market | 76,134 Shares held | 8/21/2025 | View profile |
| Alan R. Stewart Director | ▲ Buy | Grant | 28,976 Shares held | 12/31/2024 | View profile |
| Eric E. Poma Chief Executive Officer | ▲ Buy | Open Market | 25,000 Shares held | 8/21/2025 | View profile |
| Andrew C. Jackson CFO | ▲ Buy | Open Market | 2,500 Shares held | 8/21/2025 | View profile |
| Hudson Bay Capital Management LP 10% Owner | ▼ Sell | Other | 0 Shares held | 9/12/2023 | View profile |
Transaction History
| Allan Camaisa | ▼ Sell | Open Market | 850 | $1K | 12/12/2025 |
| James A. Schoeneck | ▲ Buy | Open Market | 75,000 | $150K | 8/21/2025 |
| Eric E. Poma | ▲ Buy | Open Market | 25,000 | $50K | 8/21/2025 |
| Scott Leftwich | ▲ Buy | Open Market | 125,000 | $250K | 8/21/2025 |
| Andrew C. Jackson | ▲ Buy | Open Market | 2,500 | $5K | 8/21/2025 |
| Alan R. Stewart | ▲ Buy | Grant | 12,771 | — | 12/31/2024 |
| Scott Leftwich | ▲ Buy | Grant | 11,684 | — | 12/31/2024 |
| Allan Camaisa | ▼ Sell | Open Market | 10,000 | $16K | 12/17/2024 |
| Allan Camaisa | ▲ Buy | Grant | 70,155 | $81K | 9/26/2024 |
| Scott Leftwich | ▲ Buy | Grant | 67,187 | — | 6/28/2024 |
| James A. Schoeneck | ▲ Buy | Grant | 79,687 | — | 6/28/2024 |
| Alan R. Stewart | ▲ Buy | Grant | 73,437 | — | 6/28/2024 |
| James A. Schoeneck | ▲ Buy | Option Exercise | 173,000 | $35K | 6/3/2024 |
| James A. Schoeneck | ▲ Buy | Option Exercise | 375,000 | $75K | 6/3/2024 |
| James A. Schoeneck | ▲ Buy | Grant | 375,000 | $150K | 4/18/2024 |
| Scott Leftwich | ▲ Buy | Grant | 23,783 | — | 3/29/2024 |
| James A. Schoeneck | ▲ Buy | Grant | 28,207 | — | 3/29/2024 |
| Alan R. Stewart | ▲ Buy | Grant | 25,995 | — | 3/29/2024 |
| Alfonso G. Zulueta | ▲ Buy | Grant | 5,644 | $10K | 12/21/2023 |
| Alan R. Stewart | ▲ Buy | Grant | 7,282 | $13K | 12/21/2023 |
| James A. Schoeneck | ▲ Buy | Grant | 10,625 | $19K | 12/21/2023 |
| Scott Leftwich | ▲ Buy | Grant | 8,958 | $16K | 12/21/2023 |
| Thomas A. Vecchiolla | ▲ Buy | Grant | 7,709 | $14K | 12/21/2023 |
| First Light Acquisition Group, LLC | ▼ Sell | Other | 1,931,852 | — | 9/12/2023 |
| Thomas A. Vecchiolla | ▼ Sell | Other | 6,000 | — | 9/12/2023 |
| Hudson Bay Capital Management LP | ▼ Sell | Other | 500,000 | $5.2M | 9/12/2023 |
| Polar Asset Management Partners Inc. | ▼ Sell | Open Market | 36,200 | $358K | 10/19/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
CLDI Included in After-Market Movers List
Calidi Biotherapeutics was listed among 12 health care stocks moving in Tuesday's after-market session. The stock is currently trading near its 52-week low of $1.03, reflecting significant volatility. This inclusion highlights recent price action in the biotech sector.
CLDI Included in After-Market Movers List. Calidi Biotherapeutics was listed among 12 health care stocks moving in Tuesday's after-market session. The stock is currently trading near its 52-week low of $1.03, reflecting significant volatility. This inclusion highlights recent price action in the biotech sector.